Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Operating expenses:
Research and development	$ 8,725,026	$ 5,308,662
General and administrative	5,223,101	1,391,182
Total operating expenses	13,948,127	6,699,844
Loss from operations	(13,948,127)	(6,699,844)
Other income (expense):
Interest income	14,848	282
Interest and other expense	(245,061)	0
Foreign currency transaction loss	(16,091)	0
Total other income (expense), net	(246,304)	282
Net loss	$ (14,194,431)	$ (6,699,562)
Net loss per share - basic and diluted	$ (3.84)	$ (2.73)
Weighted average common shares outstanding - basic and diluted	3,694,388	2,450,000